Abendschein D R
Cardiovascular Division, Washington University School of Medicine, St. Louis, MO 63110.
Clin Biochem. 1990 Oct;23(5):399-407. doi: 10.1016/0009-9120(90)90136-i.
Early, reliable detection of acute myocardial infarction and of coronary artery recanalization, in patients receiving thrombolytic agents, is essential to guide the course of therapy. Because the MM and MB isoenzymes of creatine kinase (CK) released from myocardium, undergo time-dependent removal of carboxyl terminal lysine residues from each monomer during exposure to circulating carboxypeptidase N, plasma profiles of the resulting isoforms are altered promptly and markedly after the release of new tissue isoenzymes. This paper reviews the results of experimental and preliminary clinical studies, showing the potential for rapid diagnosis of myocardial infarction and coronary artery recanalization by analysis of isoforms of CK isoenzymes in plasma.
对于接受溶栓药物治疗的患者,早期、可靠地检测急性心肌梗死和冠状动脉再通情况对于指导治疗进程至关重要。由于从心肌释放的肌酸激酶(CK)的MM和MB同工酶,在暴露于循环羧肽酶N期间,每个单体的羧基末端赖氨酸残基会随时间被去除,新的组织同工酶释放后,所得同工型的血浆谱会迅速且显著改变。本文综述了实验和初步临床研究结果,显示通过分析血浆中CK同工酶的同工型,具有快速诊断心肌梗死和冠状动脉再通的潜力。